The Optejet Technology Minimizes Preservative-Mediated Cytotoxicity of Conjunctival Epithelial Cells Treated with Latanoprost In Vitro DOI

Ayesha Sultan,

Deshea L Harris, Peter Lam

и другие.

Journal of Ocular Pharmacology and Therapeutics, Год журнала: 2024, Номер unknown

Опубликована: Окт. 2, 2024

Benzalkonium chloride (BAK) is a commonly used preservative to maintain sterility for multiuse eye drops such as latanoprost. One option minimize the deleterious effects of BAK in may be reduce volume administered. The aim this study was assess response cells from ocular surface latanoprost+BAK administered by Optejet technology, which dispenses microdose (∼8 µL) ophthalmical spray.

Язык: Английский

Curcumin and nanodelivery systems: New directions for targeted therapy and diagnosis of breast cancer DOI Open Access
Ruhong Zhou,

Jie Gong,

Xianguang Deng

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2024, Номер 180, С. 117404 - 117404

Опубликована: Сен. 21, 2024

Язык: Английский

Процитировано

13

The Third Dimension of Eye Care: A Comprehensive Review of 3D Printing in Ophthalmology DOI Open Access
Neil Lin, M Gagnon, Kevin Y. Wu

и другие.

Hardware, Год журнала: 2024, Номер 2(1), С. 1 - 32

Опубликована: Янв. 26, 2024

Three-dimensional (3D) printing is a process in which materials are added together layer-by-layer manner to construct customized products. Many different techniques of 3D exist, vary used, cost, advantages, and drawbacks. Medicine increasingly benefiting from this transformative technology, the field ophthalmology no exception. The possible applications eyecare vast have been explored literature, such as 3D-printed ocular prosthetics, orbital implants, educational anatomical models, well surgical planning training. Novel drug-delivery platforms also emerged because printing, offering improved treatment modalities for several pathologies. Innovative research bioprinting viable tissues, including cornea, retina, conjunctiva, presenting an avenue regenerative ophthalmic therapies future. Although further development capabilities suitable required, represents powerful tool enhancing eye health.

Язык: Английский

Процитировано

8

Janus hydrogels: merging boundaries in tissue engineering for enhanced biomaterials and regenerative therapies DOI
Yingxue Jiang, Chenhui Zhu,

Xiaoxuan Ma

и другие.

Biomaterials Science, Год журнала: 2024, Номер 12(10), С. 2504 - 2520

Опубликована: Янв. 1, 2024

In recent years, the design and synthesis of Janus hydrogels have witnessed a thriving development, overcoming limitations single-performance materials expanding their potential applications in tissue engineering regenerative medicine. hydrogels, with exceptional mechanical properties excellent biocompatibility, emerged as promising candidates for various biomedical applications, including therapies. this review, we present latest progress using commonly employed preparation methods. We elucidate surface interface interactions these discuss enhanced bestowed by unique "Janus" structure biomaterials. Additionally, explore facilitating therapies, such drug delivery, wound healing, engineering, biosensing. Furthermore, analyze challenges future trends associated utilization applications.

Язык: Английский

Процитировано

6

Applications and latest research progress of liposomes in the treatment of ocular diseases DOI
Huan Tang,

Xinnan Li,

Lin Jin

и другие.

Biointerphases, Год журнала: 2025, Номер 20(1)

Опубликована: Янв. 1, 2025

The special structure of eyes and the existence various physiological barriers make ocular drug delivery one most difficult problems in pharmaceutical field. Considering patient compliance, local administration remains preferred method anterior part eyes. However, suffers from poor bioavailability, need for frequent administration, systemic toxicity. Administration posterior eye is more difficult, intravitreal injection often used. But faces compliance likely side effects after multiple injections. development nanocarrier technology provides an effective way to solve these problems. Among them, liposomes, as widely used carrier clinical application, have characteristics amphiphilic nanostructure, easy surface modification, extended release time, good biocompatibility, etc. liposomes are expected overcome obstacles effectively deliver drugs target site improve bioavailability. This review summarized controllable properties well application research progress diseases. In addition, we routes contained eyes, prospects treatment

Язык: Английский

Процитировано

0

Inorganic biomaterials for ocular drug delivery: A comprehensive review DOI
Rudra Narayan Sahoo,

Sagar Rout,

Ankita Parmanik

и другие.

Journal of Drug Delivery Science and Technology, Год журнала: 2025, Номер unknown, С. 106667 - 106667

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Progressive Microneedles For Targeting And Intelligent Drug Delivery DOI Creative Commons

Jiaqi Li,

Qing Xia, Shuwen Ma

и другие.

Asian Journal of Pharmaceutical Sciences, Год журнала: 2025, Номер unknown, С. 101051 - 101051

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Application of Nanomaterials in the Diagnosis and Treatment of Retinal Diseases DOI

Yufei Yao,

Qiannan Cao,

Huapan Fang

и другие.

Small, Год журнала: 2025, Номер unknown

Опубликована: Апрель 8, 2025

Abstract In recent years, nanomaterials have demonstrated broad prospects in the diagnosis and treatment of retinal diseases due to their unique physicochemical properties, such as small‐size effects, high biocompatibility, functional surfaces. Retinal are often accompanied by complex pathological microenvironments, where conventional diagnostic therapeutic approaches face challenges low drug delivery efficiency, risks associated with invasive procedures, difficulties real‐time monitoring. Nanomaterials hold promise addressing these limitations traditional therapies, thereby improving precision efficacy. The applications diagnostics summarized, they enable high‐resolution imaging carrying fluorescent probes or contrast agents act biosensors sensitively detect disease‐related biomarkers, facilitating early dynamic therapeutics, functionalized nanocarriers can precisely deliver drugs, genes, antioxidant molecules target cells, significantly enhancing outcomes while reducing systemic toxicity. Additionally, nanofiber materials possess properties that make them particularly suitable for regeneration tissue engineering. By loading neurotrophic factors into scaffolds, regenerative effects be amplified, promoting repair neurons. Despite immense potential, clinical translation still requires long‐term biosafety, scalable manufacturing processes, optimization targeting efficiency.

Язык: Английский

Процитировано

0

Development, Statistical Optimization and Characterization of Ganciclovir Laden Ethyl Cellulose Nanoparticles: A 32 Factorial Design Approach DOI
Susanta Paul, Subhabrota Majumdar, Mainak Chakraborty

и другие.

Research Journal of Pharmacy and Technology, Год журнала: 2025, Номер unknown, С. 537 - 544

Опубликована: Фев. 27, 2025

Keratitis left untreated can lead to blindness. Various factors contribute ocular keratitis, primarily viral infections such as VZV and HSV. Ganciclovir is effective in treating keratitis by inhibiting DNA polymerase replication, thereby suppressing reproduction delaying the progression of disease, which ultimately reduces risk corneal scarring perforation. However, efficacy ganciclovir limited challenges related medication delivery absorption, particularly with conventional eye drops ointments that quickly evaporate upon contact cornea, necessitating frequent administration may impact patient compliance. To overcome these limitations, researchers have explored nanoparticle-based drug systems. Nanoparticles, those made from biocompatible biodegradable materials like ethyl cellulose, offer advantages controlled release, enhanced bioavailability, improved permeability. Ethyl cellulose nanoparticles effectively transport drugs tissues, protect them degradation, improve reducing frequency dosing minimizing side effects. In this study, was incorporated into using emulsion-solvent evaporation method. The formulation parameters, including polyvinyl alcohol concentrations, were optimized a 32 full factorial design. (B6) demonstrated lowest errors had particle size, zeta potential, encapsulation efficiency values 178.1nm, -21.53mV, 53.51%, respectively. Furthermore, batch exhibited sustained 87.14% release observed at 12 hours. Overall, study highlights potential promising system for improving treatment outcomes showing favorable characteristics delivery.

Язык: Английский

Процитировано

0

Study of Injectable Hydrogel Based on ALN/nHA Promoting Osteogenesis and Inhibiting Osteoclasts in Osteoporotic Bone Defects Repair DOI
Lu Yang, Xingyu Chen, Long Chen

и другие.

Macromolecular Bioscience, Год журнала: 2024, Номер 24(4)

Опубликована: Янв. 12, 2024

Osteoporotic bone defects cannot withstand surgery with more significant trauma due to fragility, while systemic drug therapy has formidable adverse effects. Consequently, the present study introduces an innovatively devised injectable double-crosslinked hydrogel, as a potential therapeutic avenue for addressing varied shapes of osteoporotic via minimally invasive approach. The hydrogel is formed by formation Schiff base bonds between oxidized sodium alginate (OSA) and carboxymethyl chitosan, polymerization gelatin methacrylate UV light crosslinking. Additionally, alendronate (ALN) loaded into through OSA, nanohydroxyapatite (nHA) incorporated blending. demonstrates excellent injectability, nHA improves mechanical properties can promote formation. In addition, sustain release ALN, which effect inhibiting osteoclasts. Cell studies indicate that differentiation osteoblasts inhibit activity osteoclast, so obtain better osteogenic effect. Therefore, be used repair invasive, simple treatment modality.

Язык: Английский

Процитировано

3

Challenges and advances of the stability of mRNA delivery therapeutics DOI Creative Commons
Jingyi Zhai,

Timothy R. Coté,

Y Chen

и другие.

Deleted Journal, Год журнала: 2024, Номер 01(02), С. 101 - 113

Опубликована: Март 4, 2024

mRNA therapeutics have garnered significant attention in the biomedical realm, showing immense potential across a spectrum of applications from COVID-19 to cancer treatments.Their ability trigger precise protein expression, particularly genome editing, is pivotal minimizing off-target effects.At core therapy lies dual-component system, comprising itself and delivery vehicle.The breakthrough success novel vaccines has catapulted lipid nanoparticles prominence as preferred vehicle.However, despite their US FDA approval efficacy, face challenge: poor stability at room temperature, which limits various geographic regions with disparities infrastructure technology.This review aims dissect issue inherent other platforms such polymer-based materials derivative materials.We herein endeavor unravel factors contributing instability explore strategies enhance stability.By doing so, we provide comprehensive analysis current landscape systems, highlighting both successes limitations, paving way for future advancements this rapidly evolving field.

Язык: Английский

Процитировано

2